Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study.
Cynthia AranowCornelia F AllaartZahir AmouraIan N BrucePatricia C CagnoliWalter W ChathamKenneth L ClarkRichard A FurieJames GroarkMurray B UrowitzRonald F Van VollenhovenMark DanielsNorma Lynn FoxYun Irene GreganRobert B HendersonAndré van MaurikJosephine C Ocran-AppiahMary OldhamDavid A RothDon ShanahanPaul P TakY K Onno TengPublished in: Annals of the rheumatic diseases (2024)
NCT03312907.